top of page
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube
Triplebar announces development of generative AI genomic language models
Technology

Triplebar announces development of generative AI genomic language models

Helaina raises $45m to speed-up commercialisation of human bioactive proteins
Precision fermentation

Helaina raises $45m to speed-up commercialisation of human bioactive proteins

Start-up spotlight: CytoNest
Manufacturing

Start-up spotlight: CytoNest

Every secures foundational patent for precision-fermented ovalbumin
Business

Every secures foundational patent for precision-fermented ovalbumin

Related posts

Cult Food Science is partnering with Alcheme Bio to leverage AI and machine learning to accelerate cell-based food products to market.


The company will use Alcheme Bio’s flavour optimisation platform to speed up the development of cellular agriculture products for Cult and its portfolio companies.


Alcheme Bio's proprietary approach utilises AI and machine learning to revolutionise how cell-based food companies optimise for flavour and nutrition.


Experience targets are determined early in development, significantly reducing R&D time and costs, while machine learning is utilised to design the best taste experiences and determine how those tastes should be implemented in development.


Including the Alcheme Bio platform is part of Cult’s larger strategy to build out product development infrastructure in order to accelerate cellular agriculture start-ups towards market readiness.


Lejjy Gafour, CEO of Cult, said: “When it comes to food, taste and cost are king. Regardless of how sustainable a product may be, something that tastes amazing is key for cultivated foods to be adopted. The production process is multistage, and continuous improvement is a pivotal part of high-quality manufacturing and that's why we're a big supporter of what Alcheme Bio is doing.”


Vanessa Small, CEO at Alcheme Bio, added: "Flavouring is an after-thought for most cultivated companies right now because of the limitations of today's flavouring approaches. Alcheme Bio is pioneering a unique approach to flavouring that reduces R&D costs instead of increasing them.”


Vanessa Small – who has two decades of scientific experience within organisations such as Pfizer and Abbott – founded Alcheme Bio in 2016.


#AlchemeBio #CultFoodScience #US


Cult Food Science and Alcheme Bio partner

Phoebe Fraser

21 June 2023

Cult Food Science and Alcheme Bio partner

bottom of page